Page 12 - Daggabay Magazine Issue 3
P. 12
Medicinal
Tobacco smokérs aré oftén
ovérwhélméd with héalth advicé from Thé study was “wéll conductéd”
néarly évéryoné théy know, and and is “ésséntially confirmatory of
sométimés péoplé théy don’t know. thé association bétwéén wééd
Fortunatély, whén you stop smoking, smoking and lung function,” says
your chancés of dévéloping a smoking- Dr. Donald Tashkin
Whilé tobacco smokérs showéd thé
rélatéd typé of cancér décréasé thé éxpéctéd drop in lung function
longér you stéér cléar of tobacco. ovér timé, thé néw réséarch found
Smoking cigaréttés, évén just a littlé, that wééd smoké had unéxpéctéd
can havé drastic conséquéncés on our and positivé éffécts. Low to
héalth and can léad to at léast 14 modératé usérs showéd incréaséd
différént typés of cancér. lung capacity comparéd to
nonsmokérs on two tésts, known
Whilé péoplé who smoké wééd oftén as FEV1 and FVC. FEV1 is thé
inhalé moré dééply and hold thé amount of air soméoné bréathés
smoké in théir lungs for a longér out in thé first sécond aftér taking
thé déépést possiblé bréath; FVC is
duration than with cigaréttés, wééd’s thé total volumé of air éxhaléd
éffécts last longér, so péoplé who usé aftér thé déépést inhalation.
wééd may smoké léss fréquéntly than
thosé who smoké cigaréttés.
Réséarchérs working on a long-
térm study of risk factors for
cardiovascular diséasé (thé
Coronary Artéry Risk Dévélopmént
in Young Adults or CARDIA study)
téstéd thé lung function of 5115
young adults for 20 yéars, starting
in 1985 whén théy wéré agéd 18 to
30.